SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-21-007007
Filing Date
2021-02-05
Accepted
2021-02-05 11:10:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 TO SCHEDULE 13G ea134754-13ga5alpha_gtbiopha.htm SC 13G/A 30531
  Complete submission text file 0001213900-21-007007.txt   32420
Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Subject) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-32837 | Film No.: 21594627
SIC: 2834 Pharmaceutical Preparations

Mailing Address LETTSTRASSE 32 FL-9490 VADUZ N2 00000
Business Address LETTSTRASSE 32 FL-9490 VADUZ N2 00000 011-423-2323195
ALPHA CAPITAL ANSTALT (Filed by) CIK: 0001140358 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N2
Type: SC 13G/A